Amgen Non-Current Portion of LTD and Capital Lease Obligation (Annual) Analysis

Amgen, Inc. (AMGN)

347.40 +0.33 (+0.10%) USD | NASDAQ | Jan 23, 10:51

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) for AMGN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks

Start Trial

Gilead Sciences, Inc.	Upgrade
Johnson & Johnson	Upgrade
Eli Lilly & Co.	Upgrade
Merck & Co., Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade